The way we understand neurodegenerative diseases is changing rapidly. Advances in biomarkers, neuroimaging and new therapies are transforming the diagnosis and management of conditions such as Alzheimer’s disease, Parkinson’s disease and ALS. In this context, training healthcare and research professionals is more important than ever.
The Faculty of Medicine at UVic-UCC has opened pre-enrolment for its new Master’s Degree in Neurodegenerative Diseases, a programme developed in collaboration with Ace Alzheimer Center Barcelona.
The programme is coordinated by Dr Mercè Boada and Dr Xavier Montalban, two internationally recognised leaders in the field of neuroscience.
Training tailored to the new challenges of neurology
The programme provides a multidisciplinary perspective on the diagnosis, clinical management and research of neurodegenerative diseases. Key topics include biomarkers, advanced neuroimaging, molecular genetics, neuropsychology and emerging therapeutic strategies.
These are areas that are currently reshaping clinical practice and brain health research, and that will define the future of care for people living with neurodegenerative diseases.
Training the professionals of the future
The master’s programme is aimed primarily at professionals in neurology, geriatrics, neuropsychology, biomedical research and other neuroscience-related disciplines. Its goal is to provide up-to-date, specialised training that equips participants to address the clinical and scientific challenges of the coming years.
For Ace, participating in initiatives such as this reflects its commitment to research, education and knowledge transfer. Advancing the prevention, diagnosis and treatment of dementia also means preparing the professionals who will lead the next generation of scientific and clinical advances.
